ASND logo

Ascendis Pharma A/S (ASND) Cash From Operations

Annual CFO:

-$331.21M+$174.06M(+34.45%)
December 31, 2024

Summary

  • As of today, ASND annual cash from operations is -$331.21 million, with the most recent change of +$174.06 million (+34.45%) on December 31, 2024.
  • During the last 3 years, ASND annual cash from operations has risen by +$162.44 million (+32.91%).
  • ASND annual cash from operations is now -4053.67% below its all-time high of $8.38 million, reached on December 31, 2013.

Performance

ASND Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

Quarterly CFO:

-$8.48M+$6.59M(+43.73%)
June 1, 2025

Summary

  • As of today, ASND quarterly cash from operations is -$8.48 million, with the most recent change of +$6.59 million (+43.73%) on June 1, 2025.
  • Over the past year, ASND quarterly cash from operations has increased by +$57.21 million (+87.09%).
  • ASND quarterly cash from operations is now -159.71% below its all-time high of $14.20 million, reached on September 1, 2013.

Performance

ASND Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

TTM CFO:

-$180.62M+$57.21M(+24.05%)
June 1, 2025

Summary

  • As of today, ASND TTM cash from operations is -$180.62 million, with the most recent change of +$57.21 million (+24.05%) on June 1, 2025.
  • Over the past year, ASND TTM cash from operations has increased by +$172.01 million (+48.78%).
  • ASND TTM cash from operations is now -1372.22% below its all-time high of $14.20 million, reached on September 1, 2013.

Performance

ASND TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ASND Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+34.5%+87.1%+48.8%
3Y3 Years+32.9%+93.6%+66.3%
5Y5 Years-68.2%+86.4%+29.9%

ASND Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+36.4%at high+94.9%at high+70.0%
5Y5-Year-68.2%+36.4%at high+94.9%at high+70.0%
All-TimeAll-Time-4053.7%+36.4%-159.7%+94.9%-1372.2%+70.0%

ASND Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$8.48M(+43.7%)
-$180.62M(+24.1%)
Mar 2025
-
-$15.06M(+84.3%)
-$237.82M(+28.6%)
Dec 2024
-$331.21M(+34.4%)
-$95.72M(-56.0%)
-$333.01M(-20.2%)
Sep 2024
-
-$61.36M(+6.6%)
-$276.98M(+21.5%)
Jun 2024
-
-$65.68M(+40.4%)
-$352.63M(+22.4%)
Mar 2024
-
-$110.25M(-177.8%)
-$454.42M(+9.5%)
Dec 2023
-$505.27M(+3.0%)
-$39.69M(+71.0%)
-$501.94M(+16.7%)
Sep 2023
-
-$137.00M(+18.2%)
-$602.42M(-7.0%)
Jun 2023
-
-$167.47M(-6.2%)
-$562.81M(-6.6%)
Mar 2023
-
-$157.77M(-12.6%)
-$528.13M(-2.1%)
Dec 2022
-$520.97M(-5.5%)
-$140.17M(-43.9%)
-$517.08M(+0.3%)
Sep 2022
-
-$97.40M(+26.7%)
-$518.68M(+3.4%)
Jun 2022
-
-$132.79M(+9.5%)
-$536.67M(+1.1%)
Mar 2022
-
-$146.72M(-3.5%)
-$542.60M(-9.8%)
Dec 2021
-$493.65M(-59.5%)
-$141.77M(-22.9%)
-$494.19M(-7.8%)
Sep 2021
-
-$115.39M(+16.8%)
-$458.60M(-11.7%)
Jun 2021
-
-$138.71M(-41.1%)
-$410.66M(-22.8%)
Mar 2021
-
-$98.31M(+7.4%)
-$334.29M(-8.0%)
Dec 2020
-$309.56M(-57.2%)
-$106.18M(-57.4%)
-$309.56M(-20.1%)
Sep 2020
-
-$67.46M(-8.2%)
-$257.79M(-0.1%)
Jun 2020
-
-$62.34M(+15.3%)
-$257.44M(-28.0%)
Mar 2020
-
-$73.58M(-35.2%)
-$201.08M(-2.1%)
Dec 2019
-$196.92M
-$54.41M(+18.9%)
-$196.92M(-7.1%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$67.10M(-1021.1%)
-$183.86M(-7.5%)
Jun 2019
-
-$5.99M(+91.4%)
-$171.11M(+9.3%)
Mar 2019
-
-$69.41M(-67.8%)
-$188.72M(-14.8%)
Dec 2018
-$163.75M(-52.7%)
-$41.36M(+23.9%)
-$164.46M(-7.8%)
Sep 2018
-
-$54.35M(-130.3%)
-$152.50M(-19.3%)
Jun 2018
-
-$23.60M(+47.7%)
-$127.87M(+1.6%)
Mar 2018
-
-$45.15M(-53.6%)
-$129.93M(-21.1%)
Dec 2017
-$107.27M(-61.1%)
-$29.39M(+1.1%)
-$107.33M(-11.1%)
Sep 2017
-
-$29.72M(-15.8%)
-$96.60M(-14.8%)
Jun 2017
-
-$25.66M(-13.8%)
-$84.17M(-15.1%)
Mar 2017
-
-$22.55M(-20.8%)
-$73.16M(-9.2%)
Dec 2016
-$66.57M(-38.1%)
-$18.67M(-8.0%)
-$67.00M(-12.6%)
Sep 2016
-
-$17.29M(-18.1%)
-$59.50M(-41.0%)
Jun 2016
-
-$14.64M(+10.7%)
-$42.21M(-53.1%)
Mar 2016
-
-$16.40M(-46.9%)
-$27.57M(-146.9%)
Dec 2015
-$48.20M(-97.5%)
-$11.17M(-13.6%)
-$11.17M(+54.3%)
Dec 2014
-$24.41M(-391.4%)
-$9.83M(-118.5%)
-$24.41M(-33.4%)
Sep 2014
-
-$4.50M(+32.0%)
-$18.30M(-4740.1%)
Jun 2014
-
-$6.61M(-90.7%)
$394.40K(-94.4%)
Mar 2014
-
-$3.47M(+6.8%)
$7.01M(-33.1%)
Dec 2013
$8.38M(+1100.3%)
-$3.72M(-126.2%)
$10.48M(-26.2%)
Sep 2013
-
$14.20M
$14.20M
Dec 2012
-$837.50K
-
-

FAQ

  • What is Ascendis Pharma A/S annual cash from operations?
  • What is the all-time high annual cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual cash from operations year-on-year change?
  • What is Ascendis Pharma A/S quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly cash from operations year-on-year change?
  • What is Ascendis Pharma A/S TTM cash from operations?
  • What is the all-time high TTM cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S TTM cash from operations year-on-year change?

What is Ascendis Pharma A/S annual cash from operations?

The current annual cash from operations of ASND is -$331.21M

What is the all-time high annual cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual cash from operations is $8.38M

What is Ascendis Pharma A/S annual cash from operations year-on-year change?

Over the past year, ASND annual cash from operations has changed by +$174.06M (+34.45%)

What is Ascendis Pharma A/S quarterly cash from operations?

The current quarterly cash from operations of ASND is -$8.48M

What is the all-time high quarterly cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly cash from operations is $14.20M

What is Ascendis Pharma A/S quarterly cash from operations year-on-year change?

Over the past year, ASND quarterly cash from operations has changed by +$57.21M (+87.09%)

What is Ascendis Pharma A/S TTM cash from operations?

The current TTM cash from operations of ASND is -$180.62M

What is the all-time high TTM cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM cash from operations is $14.20M

What is Ascendis Pharma A/S TTM cash from operations year-on-year change?

Over the past year, ASND TTM cash from operations has changed by +$172.01M (+48.78%)
On this page